Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Murray

Showing results (51-60 of 595) with videos related to

Pageof 60
Sort By:
Lancet (London, England)|February 11, 2023
Conflicting COVID-19 excess mortality estimates - Authors' replySimon I Hay, Christopher J L Murray,
JAMA|May 17, 2017
Global Burden of Disease Attributable to Hypertension-ReplyGregory A Roth, Christopher J L Murray
Lancet (London, England)|September 19, 2017
Measuring global health: motivation and evolution of the Global Burden of Disease StudyChristopher J L Murray, Alan D Lopez
Archives of Internal Medicine|July 1, 1999
Culture clashJ A García, J L Murray-García
Plos Medicine|December 15, 2010
Production and analysis of health indicators: the role of academiaChristopher J L Murray, Alan D Lopez
Health Economics|February 26, 2004
A multi-method approach to measuring health-state valuationsJoshua A Salomon, Christopher J L Murray
American Journal of Preventive Medicine|January 4, 2006
Eight Americas: new perspectives on U.S. health disparitiesChristopher J L Murray, Sandeep Kulkarni, Majid Ezzati
Lancet (London, England)|September 19, 2015
Improving the quality and coverage of cancer registries globally - Authors' replyChristopher J L Murray, Christina Fitzmaurice, Mohsen Naghavi
Journal of Biological Response Modifiers|February 1, 1986
In vitro inhibition of interleukin-2 production by peripheral blood lymphocytes from stage III melanoma patients by prostaglandin E2: enhancement of lymphocyte proliferation by exogenous interleukin-2 plus indomethacinJ L Murray, J Dowd, E M Hersh
Journal of Human Stress|September 1, 1983
Assessment of type A behavior in preschoolersJ L Murray, J G Bruhn, H Bunce
Pageof 60

Showing results (51-60 of 595) with videos related to

Sort By:
Pageof 60
Lancet (London, England)|February 11, 2023
Conflicting COVID-19 excess mortality estimates - Authors' replySimon I Hay, Christopher J L Murray,
JAMA|May 17, 2017
Global Burden of Disease Attributable to Hypertension-ReplyGregory A Roth, Christopher J L Murray
Lancet (London, England)|September 19, 2017
Measuring global health: motivation and evolution of the Global Burden of Disease StudyChristopher J L Murray, Alan D Lopez
Archives of Internal Medicine|July 1, 1999
Culture clashJ A García, J L Murray-García
Plos Medicine|December 15, 2010
Production and analysis of health indicators: the role of academiaChristopher J L Murray, Alan D Lopez
Health Economics|February 26, 2004
A multi-method approach to measuring health-state valuationsJoshua A Salomon, Christopher J L Murray
American Journal of Preventive Medicine|January 4, 2006
Eight Americas: new perspectives on U.S. health disparitiesChristopher J L Murray, Sandeep Kulkarni, Majid Ezzati
Lancet (London, England)|September 19, 2015
Improving the quality and coverage of cancer registries globally - Authors' replyChristopher J L Murray, Christina Fitzmaurice, Mohsen Naghavi
Journal of Biological Response Modifiers|February 1, 1986
In vitro inhibition of interleukin-2 production by peripheral blood lymphocytes from stage III melanoma patients by prostaglandin E2: enhancement of lymphocyte proliferation by exogenous interleukin-2 plus indomethacinJ L Murray, J Dowd, E M Hersh
Journal of Human Stress|September 1, 1983
Assessment of type A behavior in preschoolersJ L Murray, J G Bruhn, H Bunce
Pageof 60